Employee Mobility and Trade Secrets in the Golden Era of Life Sciences Innovation

From Proskauer on Trade Secrets on May 21, 2024

Alleged Theft of Drug Pricing Trade Secrets Could Cost Both Victim and Thief

From Proskauer in Life Sciences on November 28, 2023

FTC Continues to Stake Out Role as Key AI Regulator

From Minding Your Business on November 15, 2023

FTC Continues to Stake Out Role as Key AI Regulator

From Minding Your Business on September 26, 2023

Recent Partial Dismissal of Illinois Biometric Privacy Suit May Add Some Weight to the Scale on the Side of Defendants

From Minding Your Business on September 5, 2023

Proskauer Honors Public Service at the 15th Annual Golden Gavel Awards

From Proskauer For Good on February 16, 2023

SolarWinds: A Lesson on How Companies Victimized by Data Breaches Can Quickly Become the Target of Litigation and Regulatory Investigations

From Proskauer on Privacy Blog on November 16, 2022

Alvogen Continues IP Fight Over Cancer Drug Imbruvica

Siegmund Y. Gutman, David M. Hanna, Michelle M. Ovanesian and Gourdin W. Sirles are mentioned for representing Alvogen.

From Law360 on October 7, 2022

When Nondisclosure Agreements and Pharmaceutical Trade Secrets Intersect

From Proskauer in Life Sciences Blog on December 15, 2021

President Biden’s Executive Order on Competition Signals Potential Changes Affecting Patents in the Healthcare Sector

From Proskauer in Life Sciences Blog on July 28, 2021